Endothelial dysfunction has been recognized as a pathophysiologic mechanism in the progression of heart failure (HF). However, little attention has been given to the ability of dietary approaches to improve endothelial function. This study examined the effects of the Dietary Approaches to Stop Hypertension (DASH) diet on endothelial function, exercise capacity, and quality of life in patients with chronic symptomatic (stage C) HF. Forty-eight patients were randomized to follow the DASH diet (n = 24) or the general HF dietary recommendations (n = 24). Endothelial function was assessed by measuring large and small arterial elasticity (LAE and SAE) at rest. Exercise capacity (measured with the 6-minute walk test) and quality of life (measured with the Minnesota Living with Heart Failure Questionnaire) at baseline and 3 months were also evaluated. Patients were older adults with an average HF duration of 5 years. LAE at 1 month improved significantly in the DASH diet group (P < 0.01). Overall LAE and SAE scores at 3 months also improved; however, the net changes were not statistically significant. The DASH group had better exercise capacity (292 m vs 197 m; P = 0.018) and quality of life scores (21 vs 39; P = 0.006) over time, while sodium intake levels at 1, 2, and 3 months were comparable between the groups. Adhering to the DASH diet improved arterial compliance initially and improved exercise capacity and quality of life scores at 3 months. The DASH diet may be an important adjunctive therapy for patients with symptomatic HF.
H eart failure (HF) remains a leading illness responsible for signifi cant morbidity and mortality in the United States. Current HF treatment guidelines provide no specifi c recommendations for dietary intake. Patients with HF typically follow dietary guidelines for prevention of coronary heart disease (1) . Th e Dietary Approaches to Stop Hypertension (DASH), a carbohydrate-rich and low-fat diet that emphasizes fruits and vegetables, has been formally adopted into the 2013 dietary guidelines for cardiovascular risk prevention (2, 3) . Endothelial dysfunction underlies pathophysiologic mechanisms in the progression of HF and may be an important therapeutic tool in the management and prevention of HF. Several components of the DASH diet may be partly responsible for its salutary eff ects and infl uence on endothelial function (4) (5) (6) (7) (8) . Th is study examined the eff ects of the DASH diet on endothelial function, exercise capacity, and quality of life in patients with chronic symptomatic (stage C) HF.
METHODS
A single-center randomized controlled study was conducted. Patients were randomly assigned via a computerized assignment log into the DASH diet regiment or the comparison group, which required patients to follow the general HF dietary recommendations for 3 months. Th e study comprised 48 stable patients with chronic symptomatic (stage C) HF from the outpatient adult HF clinic at Advocate Christ Medical Center between February and July 2013. Institutional review board approval was obtained in January 2013. Th e study duration was 6 months. Inclusion criteria included adults over 18 years of age with stage C/New York Heart Association (NYHA) functional classes I-III and systolic or diastolic HF for at least 6 months. Th e patients were taking recommended medications for HF. Exclusion criteria included serum creatinine >3 mg/dL, allergy or intolerance to components of the DASH diet, chronic infl ammatory bowel disease aff ecting gastrointestinal absorption, inability to perform the 6-minute walk test due to severe musculoskeletal disease, and dependency on using a walker or a cane for ambulation.
After written informed consent was obtained, patients were randomized, using a block-randomization algorithm, to be in the DASH group (n = 24) or the comparison group (n = 24) for 3 months in addition to receiving their standard HF medical therapy. Patients in the DASH group were provided with an educational packet consisting of a copy of the US Department of Health and Human Services DASH eating plan guidebook (9); a DASH shopping list (10), containing various DASH diet components from which patients could choose and a reference Impact of the DASH diet on endothelial function, exercise capacity, and quality of life in patients with heart failure Luay Rifai, MD, Carol Pisano, RN, Janel Hayden, RD, Suela Sulo, PhD, and Marc A. Silver, MD
for the dietary components they were encouraged to consume for the duration of the study; and a daily and weekly food diary. Patients in the comparison group had no changes to their dietary habits other than the current general admonitions for diet in HF.
At the initial visit, all patients received further education regarding their diet from our outpatient dietitian. Th e same dietitian conducted monthly in-person visits and weekly or biweekly phone calls to counsel patients and reinforce their respective diets. In-person sessions were approximately 15 minutes in duration, in a one-on-one setting, and tailored to the individual patient's comorbidities. To more accurately assess the degree of concordance with the DASH diet, patients were assessed monthly using a DASH diet index developed by Folsom et al (11) . Th e scoring system was based on the premise that each of the major DASH diet guidelines should contribute equally to the total index score. Th e index has 11 items, and the score ranges from 0 to 11, with higher scores indicating higher levels of concordance. During the interview with the dietitian, the reported intake of sodium was estimated from the patients' corresponding food diaries and included in a food frequency questionnaire. Baseline data included demographic characteristics, clinical history, physical exam, NYHA functional class, body mass index, quality of life as measured by the Minnesota Living with Heart Failure Questionnaire (MLHFQ) (12), ejection fraction available from recent transthoracic echocardiogram, and serum markers known to infl uence HF: electrolyte measurements (sodium, potassium, magnesium), creatinine, B-type natriuretic peptide (BNP), galectin-3, and peripheral (SpO 2 ) and cerebral (SctO 2 ) oxygen saturations.
Data collected throughout the study included exercise capacity as measured by the 6-minute walk test (13) , weight, and DASH diet index score for compliance. To assess endothelial function, large and small arterial elasticity (LAE and SAE) at rest were measured using the pressure pulse contour analysis technique with the HDI/PulseWave TM (Hypertension Diagnostics, Inc., Eagan, MN). Th e device obtains radial artery waveforms with a calibrated proprietary tonometer. Th e tonometer consists of a 1.27 cm-diameter stainless-steel canister with a 0.15 mm-thick stainless-steel diaphragm internally connected to a double-plated ceramic piezoelectric element used to amplify the waveform signal. Th e tonometer is housed inside a holding and positioning device that is wrapped around the patient's arm, supported by an angulated "wrist stabilizer," achieving complete stability of position after the tonometer has been applied. Th e obtained waveforms are calibrated to the systolic and diastolic cuff pressure values of an integrated oscillometric device (cuff placed on the contralateral arm with respect to the tonometer). A computer-based Windkessel model of the circulation was used to match the diastolic pressure decay of the tonometrically obtained waveforms and to quantify changes in arterial waveform morphology in terms of LAE and SAE. Th e values were obtained during a recording period of approximately 2 minutes. Th e instrument provides separate measurements of LAE and SAE, which are sensitive markers for endothelial dysfunction (14) (15) (16) .
Hemodynamic parameters were also obtained using the HDI/PulseWave TM , including mean arterial blood pressure, heart rate, systemic vascular resistance, stroke volume, estimated cardiac output, and estimated cardiac index. Th e primary endpoint was the impact of the DASH diet on endothelial function, measured by LAE and SAE. Th e secondary endpoints were changes in hemodynamic parameters, exercise capacity, and quality of life during the 3-month follow-up period.
A power analysis was performed with the Student t test to account for diff erences in endothelial function between the groups. Based on the results of Fuentes et al (5) , and assuming a mean change in endothelial function of 0.5 to 3.0 mL/mm Hg, estimated group standard deviations of 2.0 and 2.3, and α of 0.05, a minimum of 11 patients in each group was required to achieve 80% power to detect a diff erence of 3.5 between the groups. To account for potential diff erences in the secondary outcomes of interest and for the attrition rate throughout the 3-month period, the sample was increased to 24 patients in each group.
Descriptive analyses were calculated on all variables as appropriate. LAE and SAE were compared with baseline values using repeated-measures analysis of variance. Th e baseline characteristics and secondary outcomes of interest were compared using Student's t test, chi-square or Fisher's exact test, MannWhitney U test, or Wilcoxon signed rank test depending on variable type and distribution. All data were analyzed using the SPSS software package, version 20.0 (SPSS Inc., Chicago, IL), and a P value of 0.05 was defi ned as statistically signifi cant. Table 1 describes patients' demographic and clinical characteristics. Overall, they were older adults, with an average HF duration of 5 years. No signifi cant diff erences in demographic and clinical characteristics were found between the groups (P values > 0.05). Table 2 compares the results of the groups' outcomes. Although patients in the DASH group reported better LAE and SAE scores over time, the net changes did not reach statistical signifi cance (P values > 0.05). Th e dietary compliance (as reported by the DASH index score) improved over time, but this improvement was not statistically signifi cant (P > 0.05). Th e LAE and SAE measurements over time for both groups are also summarized in Figure 1 . No statistically signifi cant diff erences were reported for 6-minute walk test scores at baseline. However, patients in the DASH group achieved better distances over time than those in the comparison group (Figure 2) . MLHFQ scores at baseline were similar between the groups (P = 0.056); however, patients in the DASH group reported improved MLHFQ scores at 3-month follow-up (21 vs. 39; P = 0.006) ( Figure 3) . Although more patients in the comparison group had sodium intake levels >1500 mg/day at baseline, groups were comparable regarding the changes in sodium intake levels at 1, 2, and 3 months (P values > 0.05). No statistically signifi cant diff erences between the DASH and comparison groups were found for weight, body mass index, BNP, or SctO2 at baseline or for hemodynamic parameters, SctO2, or BNP at any time during the study. Th e DASH dietary plan was well tolerated in our patients; no serious adverse eff ects were noted. None of the patients had a signifi cant health event, including HF exacerbation requiring hospitalization. All participating patients were alive 6 months after study completion.
RESULTS

DISCUSSION
Th e clinical practice guidelines for HF endorse with reasonable evidence dietary recommendations for people at risk of HF (stages A and B), while few patients with a diagnosis of HF (stages C and D) meet the general nutritional recommendations (17, 18) . Endothelial dysfunction has been recognized as a pathophysiologic mechanism in the progression of HF, and several pharmacologic and nonpharmacologic prevention and treatment strategies have been proposed (19) (20) (21) (22) . Th e eff ects of the DASH diet on endothelial function in patients with chronic symptomatic (stage C) HF using pulse contour analysis were assessed. Signifi cant improvement in LAE was observed in patients who received the DASH diet for 1 month, but the change was less prominent at 2 and 3 months. No signifi cant change in SAE over time was found in either group.
Since dietary patterns are complex mixtures of foods and nutrients, it is not clear whether the salutary eff ects of DASH on endothelial function are due to the vasodilatory eff ect of micronutrients (e.g., magnesium) in the DASH diet, the possible mediation of nitric oxide release, direct vasodilation, the interaction between foods and micronutrients, or a combination of these mechanisms. Another possible explanation is the antioxidant properties of components of the DASH diet, conceivably producing protective eff ects through preservation of endothelial function and antiinfl ammatory processes. Hummel et al supported the desirable infl uence of the DASH diet in HF on patients' blood pressure, arterial stiff ness, oxidative stress (23) , as well as ventricular diastolic function and arterial coupling (24) .
Although the change in LAE and SAE in the DASH diet group was more prominent in the short term and was not sustained beyond 1 month, an improvement in clinical parameters of prognostic value in HF (6-minute walk test and MLHFQ) was evident at 3 months. Th ese results are in line with recent studies demonstrating short-term eff ects of the DASH diet in mechanisms contributing to HF (23, 24) , thus suggesting that the DASH diet may also improve HF through autonomic and cardiac mechanisms other than improving endothelial function.
Patients with HF continue to consume large quantities of sodium daily. Based on previous recommendations and in accordance with the DASH diet index score for assessment of adherence, the sodium dietary goal for the study was set at 1500 mg/day (11, 25) . Although most patients consumed more than 1500 mg/day of sodium, the changes observed in LAE and SAE cannot be attributed to sodium, as no statistically signifi cant changes in estimated sodium intake were found in the groups during the study time. However, more data are needed to support a specifi c sodium intake level, especially considering that emerging evidence appears to be confl icting (4, 26, 27) . Newer and more reliable means of assessing longer-term sodium intake are needed to replace current measures that are episodic, are prone to recall bias (e.g., food frequency questionnaires), and may not be refl ective of the overall sodium intake patterns (e.g., 24-hour urinary sodium measurements) (28) .
Th e DASH index score trended toward greater compliance over time. Th is may refl ect a more realistic expectation of transitioning into a new dietary lifestyle, in addition to implementing proper reinforcement to patient education. Th e DASH diet index was chosen over other available indexes for its simplicity and to supplement patients' self-reported food diaries. However, to improve adherence and behavioral modification rates, further exploration is needed to understand how to best implement the DASH dietary recommendations. Also, since the DASH diet is recommended to the public for the prevention of cardiovascular disease, a metric to assess consistency with this diet may be useful in clinical practice.
Th is study has several limitations. Th e results are hypothesis generating and cannot be generalized to all patients with HF. No blinding techniques were used, potentially affecting the interpretation of the results, especially the endothelial function levels and 6-minute walk test results. A dietary intervention other than the general dietary recommendations was used to evaluate the eff ect on endothelial function in HF over time. A limitation of dietary intervention studies is the lack of accurate measurement of individual components. It is unclear which specifi c DASH components contributed to the observed eff ects. Although multiple educational and compliance interventions were made available to the patients, they selected and consumed the food at their own discretion, allowing for extraneous variables to infl uence the study results. Adherence was self-reported rather than confi rmed via objective tests, e.g., collection of 24-hour urine to assure equivalence in sodium intake. Food diaries and DASH diet scores, however, indicated good dietary adherence that improved over time from baseline dietary patterns for the DASH group. It is unknown whether our short-term results could be sustained in a cohort with complete freedom of food choice. Although no signifi cant diff erences in demographics were found between the groups, more black patients enrolled in this study compared with previous dietary intervention studies. Th is is of interest since black patients are especially sensitive to the eff ects of micronutrients in the DASH diet (29) . Finally, a repeat measurement of left ventricular ejection fraction was not part of this study. In patients with HF, the DASH diet was associated with favorable changes in LAE, exercise capacity, and quality of life scores. Integrating the DASH diet into the dietary patterns of patients with HF could hold potential benefi cial eff ects in decreasing the progression of endothelial dysfunction. To determine whether the particular positive eff ect on endothelial dysfunction and other possible salutary eff ects of DASH can be translated to clinical practice merits further investigation. Th ese fi ndings could inform the design of larger studies in the future that could incorporate well-characterized, more rigorous, and individualized nutritional management, while being mindful of the complex pathophysiology of HF. Th is study is one of the few randomized controlled trials to evaluate a dietary pattern in patients with HF, where little information is available to defi ne optimal nutrient intakes and food patterns.
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